Clinical Trials List
Protocol Number聯亞生技開發股份有限公司
Not yet recruiting
2021-08-30 - 2022-08-30
Phase II/III
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
11100 participants
